UBS O'Connor’s Gilead Sciences GILD Stock Holding History

UBS O'Connor’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-30,000	Closed	-$7.8K	–	544
2024 Q2	$7.8K	Buy	+30,000	New	+$2M	﹤0.01%	511

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

UBS O'Connor's GILD Position: Q3 2024 in Review

UBS O'Connor sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 10,000 shares — an estimated $686K sold.

UBS O'Connor first reported a position in GILD in Q2 2013 and held it in 3 quarters. The position peaked at $7.58M in Q2 2013. 1,721 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

UBS O'Connor reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
UBS O'Connor sold 10,000 Gilead Sciences shares in Q3 2024, an estimated $686K.
UBS O'Connor first reported a position in Gilead Sciences in Q2 2013 and held it in 3 quarters.
UBS O'Connor's Gilead Sciences position peaked at $7.58M in Q2 2013.
1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.